Clinical trial
Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating…
NCT00002680 · Yale University, Other · Completed
Key facts
| NCT number | NCT00002680 |
|---|---|
| Title | Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer |
| Official title | Phase II Trial of Sequential High-Dose Alkylating Agents in Metastatic Breast Cancer |
| Lead sponsor | Yale University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, cyclophosphamide, megestrol acetate, melphalan, tamoxifen citrate, thiotepa, conventional surgery, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 40 |
| Start date | Feb 1, 1994 |
| Primary completion | Dec 1, 2000 |
| Completion | Dec 1, 2000 |
| First posted | Apr 29, 2004 |
| Last update posted | Jul 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: